Human papillomavirus type 5 in primary keratinocytes from psoriatic skin

Experimental Dermatology

Volumn 14, Issue 11, 2005, Pages 824-829

  Simeone, Paola ^a   Teson, Massimo ^b   Latini, Alessandra ^c   Carducci, Massimo ^c   Venuti, Aldo ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Cytokines; HPV5; Human papillomavirus; Interleukin; Psoriasis

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; PARAFFIN; SUPERANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE ACTIVATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS TYPE 5; IMMUNOSTIMULATION; KERATINOCYTE; MALE; NONHUMAN; PAPILLOMA VIRUS; PAPOVAVIRUS; PATHOGENESIS; PLASTIC SURGERY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PSORIASIS; SKIN BIOPSY; SUPERINFECTION; TISSUE SECTION; VIRUS DETECTION; VIRUS GENE; VIRUS REPLICATION;

ADULT; AGED; CELLS, CULTURED; CYTOKINES; DNA, VIRAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KERATINOCYTES; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PSORIASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SKIN;

EID: 27744519560     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00358.x     Document Type: Article

References (21)

1. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003: 31: 52-56.
2. Favre M, Orth G, Majewski S et al. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998: 110: 311-317.
3. Majewski S, Favre M, Orth G, Jabloska S. Is human papillomavirus type 5 the putative autoantigen involved in psoriasis? J Invest Dermatol 1998: 111: 541-542.
4. de Villiers E M, Ruhland A. Do specific human papillomavirus types cause psoriasis? Arch Dermatol 2001: 137: 384.
5. Zambruno G, Marchisio P C, Marconi A et al. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αvβ6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 1995: 129: 853-865.
6. Berkhout R J, Tieben L M, Smits H L et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995: 33: 690-695.
7. Haller K, Stubenrauch F, Pfister H. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 1995: 214: 245-255.
8. Saiki R K, Bugawan T L, Horn G T, Mullis K B, Erlich H A. Analysis of enzymatically amplified beta-globin and HLADQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986: 324: 163-166.
9. Teunissen M B M, Koomen C W, de Waal Malefyt R, Wierenga E A, Bos J. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998: 111: 645-649.
10. Ohta Y, Katayama I, Funato T et al. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 1991: 283: 351-356.
11. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder J M, Christophers E. Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 1996: 106: 526-530.
12. Debets R, Hegmans J P, Croughs P et al. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 1997: 158: 2955-2963.
13. Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch Dermatol Res 2001: 293: 334-342.
14. Chamian F, Krueger J G. Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis. Curr Opin Rheumatol 2004: 16: 331-337.
15. Ruhland A, de Villiers E M. Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines. Int J Cancer 2001: 91: 828-834.
16. Majewski S, Jablonska S. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis. Exp Dermatol 2003: 12: 721-728.
17. Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994: 264: 1141-1145.
18. Nair R P, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997: 6: 1349-1356.
19. Ramoz N, Rueda L A, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999: 112: 259-263.
20. Ramoz N, Taieb A, Rueda L A et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000: 114: 1148-1153.
21. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002: 138: 649-654.